Ischemic hepatitis: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Histopathology_of_shock_liver_(intermediate_magnification),_annotated.jpg|Histopathology of shock liver (intermediate magnification) | |||
File:Ventricular_fibrillation.png|Ventricular fibrillation | |||
File:Congestive_hepatopathy_high_mag.jpg|Congestive hepatopathy high magnification | |||
</gallery> | |||
Revision as of 04:11, 18 February 2025
Ischemic hepatitis or shock liver is a condition characterized by a rapid decrease in liver function, typically caused by a lack of blood flow to the liver. The condition is most commonly seen in critically ill patients.
Causes
The primary cause of ischemic hepatitis is a significant decrease in blood flow to the liver. This can occur as a result of heart failure, shock, or sepsis. Other potential causes include hypotension, cardiac arrest, and pulmonary embolism.
Symptoms
Symptoms of ischemic hepatitis can vary widely, but often include jaundice, nausea, vomiting, and abdominal pain. In severe cases, patients may experience confusion, lethargy, or coma.
Diagnosis
Diagnosis of ischemic hepatitis typically involves a combination of blood tests, imaging studies, and sometimes a liver biopsy. Blood tests may show elevated liver enzymes, indicating liver damage. Imaging studies such as an ultrasound or CT scan can help to rule out other potential causes of liver dysfunction.
Treatment
Treatment for ischemic hepatitis primarily involves addressing the underlying cause of the decreased blood flow to the liver. This may involve medications to improve heart function, antibiotics to treat sepsis, or surgery to remove a blood clot. In some cases, a liver transplant may be necessary.
Prognosis
The prognosis for ischemic hepatitis can vary widely depending on the underlying cause and the patient's overall health. With prompt treatment, some patients may fully recover, while others may experience long-term liver damage or failure.


